Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.15T
Market cap1.15T
Price-Earnings ratio
42.90
Price-Earnings ratio42.90
Dividend yield
0.54%
Dividend yield0.54%
Average volume
3.67M
Average volume3.67M
High today
$1,212.65
High today$1,212.65
Low today
$1,180.30
Low today$1,180.30
Open price
$1,195.80
Open price$1,195.80
Volume
239.50K
Volume239.50K
52 Week high
$1,238.00
52 Week high$1,238.00
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

As of today, Eli Lilly(LLY) shares are valued at $1,211.91. The company's market cap stands at 1.15T, with a P/E ratio of 42.90 and a dividend yield of 0.54%.

During the trading session on 2026-07-02, Eli Lilly(LLY) shares reached a daily high of $1,212.65 and a low of $1,180.30. At a current price of $1,211.91, the stock is +2.7% higher than the low and still -0.1% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 239.5K, versus its average volume of 3.67M.

The stock's 52-week range extends from a low of $623.78 to a high of $1,238.00.

The stock's 52-week range extends from a low of $623.78 to a high of $1,238.00.

LLY News

Simply Wall St 13h
Eli Lilly Faces China Trial Probe While Handing Verzenios Rights To Innovent - simplywall.st

...

Eli Lilly Faces China Trial Probe While Handing Verzenios Rights To Innovent - simplywall.st
24/7 Wall St. 21h
Eli Lilly Price Prediction: The Case for Double-Digit Upside

Eli Lilly Price Prediction: The Case for Double-Digit Upside By Vandita Jadeja Published Jul 1, 1:18PM EDT Quick Read LLY earns a BUY rating with a $1,349 pri...

Eli Lilly Price Prediction: The Case for Double-Digit Upside
Benzinga 21h
Innovent, Eli Lilly Partner to Commercialize Breast Cancer Drug in China

Innovent Biologics, Inc. and Eli Lilly and Co. (NYSE:LLY) on Tuesday entered into a distribution and promotion agreement for Eli Lilly’s breast cancer therapy V...

Innovent, Eli Lilly Partner to Commercialize Breast Cancer Drug in China

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
9.7%
Sell
6.5%

More LLY News

TipRanks 2d
Eli Lilly Stock Retreats as China Threats Emerge

Eli Lilly’s (LLY) stock is down about 2% on June 30 amid reports that generic versions of weight-loss drugs are emerging in China. Unlock powerful investing to...

Nasdaq 2d
Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick

A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (Symbol: JNJ) is the #8 broker pick, on average, out of the 30 stocks ma...

Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick
24/7 Wall St. 2d
AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity By Rich Duprey Published Jun 30, 9:38AM EDT Quick Read AI cuts drug di...

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity
TipRanks 2d
Innovent Biologics, Eli Lilly enters Verzen distribution and promotion agreement

Innovent Biologics (IVBXF) and Eli Lilly (LLY) jointly announced that they have entered into a distribution and promotion agreement regarding Lilly’s CDK4 & 6 i...

CNBC 2d
Medicare will start covering obesity drugs for the first time. Here's what patients should know

Key Points Starting Wednesday, eligible seniors with Medicare coverage can access GLP-1s for obesity with a copay of just $50 per month through a temporary prog...

Medicare will start covering obesity drugs for the first time. Here's what patients should know
Nasdaq 2d
Big Pharma Has a Case of Merger Mania

In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Tyler Crowe, Matt Frankel, and Lou Whiteman take a dive into what’s driving the m...

Big Pharma Has a Case of Merger Mania
Simply Wall St 3d
Eli Lilly Signs BioArctic Deal To Pursue BrainTransporter Neurodegeneration Research

Eli Lilly (NYSE:LLY) has entered a research and collaboration agreement with BioArctic focused on neurodegenerative disease treatments. The partnership centers...

Eli Lilly Signs BioArctic Deal To Pursue BrainTransporter Neurodegeneration Research

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.